These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 1666769

  • 1. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G, Stone-Elander S, Halldin C, Roland PE, Swahn CG, Haaparanta M, Solin O, Lindqvist M, Widén L.
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract] [Full Text] [Related]

  • 2. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD.
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [Abstract] [Full Text] [Related]

  • 3. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K, Lucignani G, Moresco RM, Rizzo G, Gilardi MC, Messa C, Colombo F, Fazio F, Sokoloff L.
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative measurement of glucose utilization in dog brain using positron emission tomogram and 18FDG.
    Hatazawa J, Yamaguchi T, Ito M, Kubota K, Fujiwara T, Yamaura H, Matsuzawa T, Kiyosawa M, Ido T.
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):65-8. PubMed ID: 6611587
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG.
    Suhonen-Polvi H, Ruotsalainen U, Ahonen A, Haaparanta M, Aho K, Riikonen R, Kero P, Korvenranta H, Simell O, Wegelius U.
    Acta Radiol Suppl; 1991 Dec; 376():173. PubMed ID: 1666770
    [No Abstract] [Full Text] [Related]

  • 12. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.
    Pawlik G, Wienhard K, Herholz K, Wagner R, Heiss WD.
    Prog Brain Res; 1984 Dec; 62():253-62. PubMed ID: 6335919
    [No Abstract] [Full Text] [Related]

  • 13. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC, Lucignani G, Sokoloff L.
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract] [Full Text] [Related]

  • 14. Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
    Wahl RL, Cody R, Hutchins G, Mudgett E.
    N Engl J Med; 1991 Jan 17; 324(3):200. PubMed ID: 1984203
    [No Abstract] [Full Text] [Related]

  • 15. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1986 Jan 17; 10(3-5):309-21. PubMed ID: 2948218
    [Abstract] [Full Text] [Related]

  • 16. [Positron emission tomography of lung cancer using 18F-2-fluoro-2-deoxy-D-glucose and L-[11C-methyl]-methionine].
    Matsuzawa T, Fujiwara T, Abe Y, Itoh M, Fukuda H, Yamaguchi K, Kawai H, Kubota K, Yamaguchi T, Miyazawa H.
    Kokyu To Junkan; 1987 Jan 17; 35(1):15-20. PubMed ID: 3031787
    [No Abstract] [Full Text] [Related]

  • 17. Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication.
    Baron JC, Lebrun-Grandie P, Collard P, Crouzel C, Mestelan G, Bousser MG.
    J Nucl Med; 1982 May 17; 23(5):391-9. PubMed ID: 6978932
    [Abstract] [Full Text] [Related]

  • 18. Effect of cervical spinal cord stimulation (cSCS) on cerebral glucose metabolism and blood flow in a vegetative patient assessed by positron emission tomography (PET) and single photon emission computed tomography (SPECT).
    Momose T, Matsui T, Kosaka N, Ohtake T, Watanabe T, Nishikawa J, Abe K, Tanaka J, Takakura K, Iio M.
    Radiat Med; 1989 May 17; 7(5):243-6. PubMed ID: 2629037
    [Abstract] [Full Text] [Related]

  • 19. [A new method for analyzing the local cerebral metabolic rate of glucose using an 18FDG positron CT-image].
    Endo M, Shishido F, Fukuda N, Matsumoto T, Iinuma TA, Tateno Y, Yamasaki T, Takashima T, Tamachi S.
    Kaku Igaku; 1983 Jun 17; 20(5):699-702. PubMed ID: 6604830
    [No Abstract] [Full Text] [Related]

  • 20. Decreased cerebral glucose utilization in myotonic dystrophy.
    Fiorelli M, Duboc D, Mazoyer BM, Blin J, Eymard B, Fardeau M, Samson Y.
    Neurology; 1992 Jan 17; 42(1):91-4. PubMed ID: 1734329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.